Abstract
Earlier studies reported by Howard1 and Lehninger2 suggested that a substance containing Pi and citrate, and tentatively assigned the structure of phosphocitrate, existed in nature and was a potent inhibitor of hydroxyapatite (HAP) formation. These observations led us to attempt to isolate and characterize phosphocitrate from biological sources with a view to defining a physiological role for this compound in calcification systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. E. Howard, Johns Hopkins Med. J. 139:239 (1976).
A. L. Lehninger, Horiz. Biochem. Biophys. 4:1 (1977).
G. Williams and J. D. Sallis, Anal. Biochem. 102:365 (1980).
G. B. Jones, Anal. Biochem. 21:286 (1967).
G. Williams, E. S. Holdsworth and J. D. Sallis, Clin. Exp. Pharm. Physiol, (in press).
G. Williams and J. D. Sallis, Biochem. J. 184:181 (1979).
S. T. Ohnishi, Anal. Biochem. 86:201 (1978).
H. H. Donaldson, Am. J. Anat. 26:237 (1920).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Springer Science+Business Media New York
About this chapter
Cite this chapter
Williams, G., Sallis, J.D. (1981). The Sources of Phosphocitrate and its Role as an Inhibitor of Calcium Phosphate and Calcium Oxalate Crystallization. In: Smith, L.H., Robertson, W.G., Finlayson, B. (eds) Urolithiasis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8977-4_93
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8977-4_93
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8979-8
Online ISBN: 978-1-4684-8977-4
eBook Packages: Springer Book Archive